Septerna, Inc. (SEPN) vs Zenas BioPharma, Inc. (ZBIO)
Septerna, Inc. and Zenas BioPharma, Inc. are both Biotechnology companies. Septerna, Inc. and Zenas BioPharma, Inc. are of similar size ($1.8B and $1.8B). Zenas BioPharma, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (0.00% vs −189.0%). Across the 13 metrics below, Septerna, Inc. leads on 8 and Zenas BioPharma, Inc. on 5.
Valuation
Profitability
| Metric | SEPN | ZBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (44.04%) | 0.00% | 0.00% |
| Net margin | (24.51%) | 0.00% | 0.00% |
| Free cash flow margin | 118.93% | 0.00% | 0.00% |
| Return on equity | (6.34%) | (199.04%) | (57.72%) |
| Return on assets | (4.94%) | (97.39%) | (49.22%) |
| Return on invested capital | (189.01%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack